Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
British Journal of Pharmacology|November 15, 2005
Characterization of the Mas-related gene family: structural and functional conservation of human and rhesus MrgX receptorsEthan S Burstein, Thomas R Ott, Michele Feddock, et al.
Plos One|March 22, 2013
Functional enhancement of AT1R potency in the presence of the TPαR is revealed by a comprehensive 7TM receptor co-expression screenJonas Tind Hansen, Christina Lyngsø, Tobias Speerschneider, et al.
Journal of Medicinal Chemistry|August 30, 2008
Discovery of potent and selective small-molecule PAR-2 agonistsJimmi Gerner Seitzberg, Anne Eeg Knapp, Birgitte Winther Lund, et al.
Neuroscience Letters|July 9, 2018
A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the ratDavid H Malin, Mallori M Henceroth, Joanne Elayoubi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2026
Nonclinical characterization of ACP-204, a novel selective serotonin receptor subtype 2A receptor inverse agonistEthan S Burstein, Roger Olsson, Niklas Skold, et al.
Biochemical Pharmacology|March 16, 2010
An angiotensin II type 1 receptor activation switch patch revealed through evolutionary trace analysisMarie Mi Bonde, Rong Yao, Jian-Nong Ma, et al.
Molecular Imaging|August 25, 2016
Preclinical PET Neuroimaging of [11C]BexaroteneBenjamin H Rotstein, Michael S Placzek, Hema S Krishnan, et al.
Behavioural Pharmacology|May 20, 2025
5-HT2A receptor inverse agonist attenuates morphine withdrawal syndrome and its aversiveness in ratsPing-Hsun Tsai, Erica R Morales, Yvonne Y Reed, et al.
ACS Chemical Neuroscience|July 11, 2017
Ligand Dependent Switch from RXR Homo- to RXR-NURR1 HeterodimerizationMarcel Scheepstra, Sebastian A Andrei, Rens M J M de Vries, et al.
Pageof 6